The SEAMLESS Study: Smartphone App-based Mindfulness for Cancer Survivors
Launched by UNIVERSITY OF CALGARY · Jun 4, 2018
Trial Information
Current as of May 05, 2025
Completed
Keywords
ClinConnect Summary
BACKGROUND Cancer patients who are in the transition phase to survivorship after completing their final treatments need psychosocial interventions to manage stressors such as anxiety, depression, and fear of cancer recurrence. Smartphone app-based health interventions are an innovative way to deliver psychosocial cancer-care. In the SEAMLESS study, the investigators aim to evaluate an app-based mind-body intervention (MBI) in cancer survivors.
The need for psychosocial interventions for cancer survivors has been highlighted by the Institute of Medicine in their landmark survivorship report...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Men and women over the age of 18
- • 2. Diagnosed with any type of cancer (stage I-III)
- • 3. Completed active treatment (i.e. surgery, chemotherapy, radiation therapy) at least 4 months previously (ongoing hormonal therapies, AIs, tamoxifen, herceptin are not exclusionary)
- • 4. Have access to a smartphone with data connection; in case patients' do not have a data plan or an insufficient data plan with their smart phone, we will pay for their data connection (up to 0.5GB/month)
- • 5. Willing to devote 20-30 mins of time to do the mindfulness meditations and practices every day
- • 6. Sufficient cognitive function to participate in the smartphone app-based intervention
- • 7. Ability to speak and write English sufficiently to complete questionnaires
- Exclusion Criteria:
- • 1. Metastatic patients and those with ongoing chemotherapy (metastatic patients may not be stable enough to participate in the interventions and follow-up assessments).
- • 2. Cognitive impairment that would interfere with completing questionnaires or the intervention.
- • 3. Suffering from current Major Depressive Disorder, Bipolar Disorder or other psychiatric disorder that would interfere with the ability to participate.
- • 4. Practicing smartphone app-based mindfulness more than or equal to once a week
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Patients applied
Trial Officials
Linda Carlson, PhD
Principal Investigator
University of Calgary
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials